Chinese Medical Journal study reveals potential use of artificial intelligence (AI) in finding new glaucoma drugs
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-Jul-2025 06:10 ET (1-Jul-2025 10:10 GMT/UTC)
Glaucoma, the leading cause of blindness, is often marked by loss of retinal ganglion cells (RGCs). Necroptosis, a form of programmed cell death, plays a critical role in RGC death, mediated by receptor-interacting protein kinase 3 (RIPK3). A team of scientists from China leveraged advanced artificial intelligence (AI) technologies to identify RIPK3 inhibitors, including the compound HG9-91-01, which demonstrated neuroprotective effects. This AI-driven approach holds promise for developing novel therapeutic strategies for acute glaucoma.
An investigation published in National Science Review firstly presents comprehensive analysis for the spatiotemporal patterns and underlying drivers of compound low-solar-low-wind extremes over time across China. This research underscores the importance for nations engaging in progressive decarbonization to consider compound low-solar-low-wind extremes in renewable energy development and power sector planning, and proposes interregional renewable electricity transmission as a potential solution.
Researchers have developed a biomimetic artificial muscle that replicates the structure and mechanical properties of natural muscle tissue, offering a promising solution for volumetric muscle loss treatment. Published in National Science Review, the study highlights the material's superior biocompatibility, mechanical adaptability, and multifunctionality. The artificial muscle promotes myogenic differentiation, enhances angiogenesis, and demonstrates exceptional actuation performance, making it a viable candidate for applications in prosthetics and regenerative medicine. This innovation sets the stage for new directions in clinical treatments and advanced biomedical materials.
This review discusses the current and emerging gene and cell therapy strategies for Huntington's disease (HD), a neurodegenerative disorder characterized by motor dysfunction, cognitive decline, and emotional disturbances. The authors explore the potential of combination therapies, including the use of human iPSC-derived striatal neurons (hStrOs) and human umbilical cord mesenchymal stem cells (hUC-MSCs), to mitigate HD symptoms and improve treatment outcomes.
Researchers have discovered that magnesium levels within eye lens cells can significantly impact the function of gap junctions, crucial for lens transparency. This finding could lead to new treatments for cataracts and other eye diseases.